Medical Oncology

, Volume 28, Issue 4, pp 973–980 | Cite as

Improved outcome in asymptomatic recurrence following curative surgery for gastric cancer

  • Cynthia Villarreal-GarzaEmail author
  • Miriam Rojas-Flores
  • Andrea Castro-Sánchez
  • Antonio R. Villa
  • Luis García-Aceituno
  • Eucario León-Rodríguez
Original paper


The purpose of this study was to compare the outcome and resectability of patients with gastric cancer recurrence after curative surgery detected by follow-up endoscopy, according to the presence or absence of symptoms. All patients with gastric carcinoma, who underwent a curative gastrectomy, were retrospectively identified. We analyzed outcome and survival in patients compliant with routine follow-up who presented symptomatic and asymptomatic recurrence. Of the 119 resected patients, 63.0% had a recurrence, with an overall survival of 20.0 months. Fourteen patients were asymptomatic when recurrence was detected, whereas 61 patients were symptomatic. Median time to recurrence was 16.0 m for both groups. A local curative re-resection was possible in 2/14 (asymptomatic) and 1/61 (symptomatic). Asymptomatic patients had a longer median postrecurrence survival time of 9.0 months, compared with 2.0 months in the symptomatic patients (p=0.034). The median overall survival was greater in the asymptomatic vs symptomatic group (25.0 vs 20.0 months), although this did not reach statistical significance. The results from this study advocate that the presence or absence of symptoms is a good surrogate marker to assess biologic aggressiveness. The value of routine follow-up endoscopy to permit a higher rate of re-resection in asymptomatic patients remains to be established.


Gastric cancer Asymptomatic recurrence Re-resection Follow-up 



Study conception and design: Villarreal-Garza, León-Rodríguez. Collection of data: Villarreal-Garza, Rojas-Flores, Castro-Sánchez. Analysis and interpretation of data: Villarreal-Garza, Villa, León-Rodríguez. Systematic review of literature and drafting of manuscript: Villarreal-Garza, García-Aceituno. Final approval of manuscript: Villarreal-Garza, Rojas-Flores, Castro-Sánchez, Villa, García-Aceituno, León-Rodríguez.

Conflict of interest statement

The authors of the manuscript “Improved outcome in asymptomatic recurrence following curative surgery for gastric cancer” declare that there are no conflicts of interest.


  1. 1.
    Garcia M, et al. Global cancer facts & figures 2007. Atlanta: American Cancer Society; 2007.Google Scholar
  2. 2.
    Estadísticas Demográficas 2006. México: Instituto Nacional de Estadística, Geografía e Informática, 2008.Google Scholar
  3. 3.
    Leon-Rodriguez E, Dominguez A. Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition. Rev Invest Clin. 1992;44:221–7.PubMedGoogle Scholar
  4. 4.
    Green D, Ponce de Leon S, Leon-Rodriguez E, Sosa-Sanchez R. Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival. Am J Clin Oncol. 2002;25:84–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol. 1981;18:47–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Whiting J, et al. Follow-up of gastric cancer: a review. Gastric Cancer. 2006;9:74–81.PubMedCrossRefGoogle Scholar
  7. 7.
    Jensen E, Tuttle T. Preoperative staging and postoperative surveillance for gastric cancer. Surg Oncol Clin N Am. 2007;16:329–42.PubMedCrossRefGoogle Scholar
  8. 8.
    National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, 2009. Available at: Accessed April 30, 2009.
  9. 9.
    D’Angelica M, et al. Patterns of inicial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Lehnert T, Rudek B, Buhl K, Golling M. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. EJSO. 2002;28:455–61.PubMedGoogle Scholar
  11. 11.
    Lee SY, et al. The role of follow-up endoscopy after total gastrectomy for gastric cancer. EJSO. 2005;31:265–9.PubMedGoogle Scholar
  12. 12.
    Onodera H, et al. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric cancer. Hepatogastroenterology. 2004;51:82–5.PubMedGoogle Scholar
  13. 13.
    Kikuchi S, et al. Efficacy of endoscopic surveillance of the upper gastrointestinal tract following distal gastrectomy for early gastric cancer. Hepatogastroenterology. 2003;50:1704–7.PubMedGoogle Scholar
  14. 14.
    Hosokawa O, et al. Endoscopic surveillance for gastric remnant cancer after early cancer gastric. Endoscopy. 2002;34:469–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Eckardt VF, Giebler W, Kanzler G, Bernhard G. Does endoscopic follow-up improve the outcome of patients with benign gastric ulcers and gastric cancer? Cancer. 1992;69:301–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Porro A, Alberto A. Correspondence of: does endoscopic follow-up improve the outcome of patients with benign gastric ulcers and gastric cancer? Cancer. 1992;70:2741–2.PubMedCrossRefGoogle Scholar
  17. 17.
    Shchepotin I, et al. Radical treatment of locally recurrent gastric cancer. Am Surg. 1995;61:371–6.PubMedGoogle Scholar
  18. 18.
    Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Sunagawa M, et al. Reoperation of recurrent gastric cancer ± a comparative study of a resected and non-resected group. Gan No Rinsho. 1984;30:1899–903.PubMedGoogle Scholar
  20. 20.
    Tan IT, So BY. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Böhner H, Zimmer T, Hopfenmuller W, Berger G, Buhr HJ. Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.PubMedGoogle Scholar
  22. 22.
    Kodera Y, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10:898–902.PubMedCrossRefGoogle Scholar
  23. 23.
    Bennet J, et al. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201:503–10.CrossRefGoogle Scholar
  24. 24.
    Marrelli D, et al. Prediction of recurrence after radical surgery for gastric cancer. A scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.PubMedCrossRefGoogle Scholar
  25. 25.
    Motoori M, et al. Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer. 2005;114:963–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Cynthia Villarreal-Garza
    • 1
    Email author
  • Miriam Rojas-Flores
    • 1
  • Andrea Castro-Sánchez
    • 1
  • Antonio R. Villa
    • 2
  • Luis García-Aceituno
    • 1
  • Eucario León-Rodríguez
    • 1
  1. 1.Department of Medical Oncology and HematologyInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)Mexico CityMexico
  2. 2.Department of Clinical EpidemiologyInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)Mexico CityMexico

Personalised recommendations